Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of CHF 1535 (BDP/Formoterol) in COPD
NCT02000609Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone dipropionate, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Dec 2013; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02000609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000609.